Impact of neoadjuvant therapy on angioplastic lobectomy: a retrospective study
Tayeb Benkiran, Kheira Hireche, Sebastien Frey, Adeline Morisot, Aude Nguyen, Quentin Rudondy, Florent Alcaraz, Mauro Guarino, Charlotte Cohen, Abel Gomez-Caro, Jean-Phillippe Berthet · 2025
Read Impact of neoadjuvant therapy on angioplastic lobectomy: a retrospective study by Tayeb Benkiran, Kheira Hireche, Sebastien Frey, Adeline Morisot, Aude Nguyen, Quentin Rudondy, Florent Alcaraz, Mauro Guarino, Charlotte Cohen, Abel Gomez-Caro, Jean-Phillippe Berthet (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11669316.txt.
Description
Tayeb Benkiran and colleagues assess how pre-surgery treatment affects outcomes of vessel-sparing lung removal surgery for lung cancer. Their 2025 retrospective study reviews over a hundred patients at two specialist centres across twenty years.
About a third received drug or radiation therapy before the operation, which preserves lung tissue by repairing the airway and vessels. Postoperative complication rates did not differ significantly between treated and untreated groups. Mortality also showed no significant difference. Pathological upstaging was far more common in the untreated group. Five-year survival was comparable between groups. The authors conclude pre-treatment does not worsen surgical risk, and the lung-sparing operation remains a safe option afterwards.
Catalog record
| CREATOR | Tayeb Benkiran, Kheira Hireche, Sebastien Frey, Adeline Morisot, Aude Nguyen, Quentin Rudondy, Florent Alcaraz, Mauro Guarino, Charlotte Cohen, Abel Gomez-Caro, Jean-Phillippe Berthet |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |